CD274 and hepatocellular carcinoma: Given that hsa-miR-194-5p negatively regulated PD-L1 expression, the inhibition of hsa-miR-194-5p by lncRNA PCED1B-AS1 led to the upregulation of PD-L1 expression, which might boost the immunotherapy efficacy in HCC [116].